MedPath

Role of Colonic Short Chain Fatty Acids in Obesity

Not Applicable
Completed
Conditions
Obesity
Interventions
Other: Glucose
Other: Inulin
Other: Resistant Starch
Registration Number
NCT02562014
Lead Sponsor
University of Toronto
Brief Summary

The excess production of colonic short-chain-fatty-acids (SCFA) has been implicated in the promotion of obesity, but colonic fermentation of dietary-fiber to SCFA may also play a role in preventing diabetes. The investigators aimed to compare the effects of two fermentable fibers (inulin and resistant-starch) on postprandial SCFA, glucose, insulin, free-fatty acids (FFA) and gut hormone responses and to compare the responses in healthy overweight and obese (OWO) vs lean (LN) participants. Methods: Using a randomized, single blind, crossover design, 13 OWO and 12 LN overnight fasted participants were studied on 3 separate occasions. On each day they consumed a 300 mL drink containing 75g glucose (Control) or 75g glucose plus 24g inulin (IN), or 28.2g resistant-starch (RS). A standard lunch was served 4 h after the test drink.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
25
Inclusion Criteria
  • non-pregnant
  • body mass index >=20 and <=35
Exclusion Criteria
  • history of diabetes mellitus
  • history of cardiovascular disease
  • history of bowel disease
  • history of kidney disease
  • history of liver disease
  • use of antibiotics within 3 months of enrolment
  • unusual dietary habits
  • fasting glucose >6.9mmol/L
  • hematocrit below normal range for age and sex

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
OverweightGlucoseParticipants with body mass index \>25
OverweightInulinParticipants with body mass index \>25
LeanResistant StarchParticipants with body mass index \<=25
LeanGlucoseParticipants with body mass index \<=25
OverweightResistant StarchParticipants with body mass index \>25
LeanInulinParticipants with body mass index \<=25
Primary Outcome Measures
NameTimeMethod
Incremental area under the serum acetate response curveFor 6 hours after consuming the test meal
Secondary Outcome Measures
NameTimeMethod
Incremental area under the breath hydrogen response curveFor 6 hours after consuming the test meal
Incremental area under the serum propionate response curveFor 6 hours after consuming the test meal
Incremental area under the breath methane response curveFor 6 hours after consuming the test meal
Incremental area under the serum insulin response curveFor 2 hours after consuming the standard lunch
Incremental area under the serum butyrate response curveFor 6 hours after consuming the test meal
Incremental area under the serum c-peptide response curveFor 2 hours after consuming the standard lunch
Incremental area under the serum glucose response curveFor 2 hours after consuming the standard lunch
Total area under the serum free-fatty acid response curveFor 2 hours after consuming the standard lunch
© Copyright 2025. All Rights Reserved by MedPath